Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Food Recall Warning (Allergen) - Nestlé brand Drumstick Caramel Non-Dairy Frozen Dessert Cones and Drumstick Vanilla Chocolate Swirl Non-Dairy Frozen Dessert Cones recalled due to undeclared milk


Product photos are available at: https://bit.ly/3spsapn

OTTAWA, ON, April 15, 2021 /CNW/ - Nestlé Canada Inc. is recalling Nestlé brand Drumstick Caramel Non-Dairy Frozen Dessert Cones and Drumstick Vanilla Chocolate Swirl Non-Dairy Frozen Dessert Cones from the marketplace because they may contain milk which is not declared on the label. People with an allergy to milk should not consume the recalled products described below.

The following products have been sold in Alberta, British Columbia, Manitoba, Ontario, Quebec, and may have been distributed in other provinces or territories.

Recalled products

Brand

Product

Size

UPC

Codes

Nestlé

Drumstick Caramel Non-Dairy Frozen Dessert Cones

4 x 120 mL

0 55000 38383 7

All Codes

Nestlé

Drumstick Vanilla Chocolate Swirl Non-Dairy Frozen Dessert Cones

4 x 120 mL

0 55000 38384 4

All Codes

What you should do

Check to see if you have the recalled products in your home. Recalled products should be thrown out or returned to the store where they were purchased.

If you have an allergy to milk, do not consume the recalled products as they may cause a serious or life-threatening reaction.

Background

This recall was triggered by Canadian Food Inspection Agency (CFIA) test results. The CFIA is conducting a food safety investigation, which may lead to the recall of other products. If other high-risk products are recalled, the CFIA will notify the public through updated Food Recall Warnings.

The CFIA is verifying that industry is removing the recalled products from the marketplace.

Reactions

There has been one reported reaction associated with the consumption of these products.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 22:00
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 19:30
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...



News published on and distributed by: